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Background 
Oesophageal cancer is the 4th most common cause of cancer-
related fatality amongst males in the developing countries, 
and the 8th most common cause amongst males in developed 
countries.1 Although the incidence is twenty-fold higher 
in the developing world compared to developed countries, 
the spectrum of disease is different with adenocarcinoma 
being the most common form in the developed world and 
squamous carcinoma being the most common form in the 
developing world.1 Barrett’s oesophagitis (BO) with dysplasia 
is a precursor lesion for the development of adenocarcinoma 
of the oesophagus (AC) and many developed countries have 
dedicated guidelines for this condition.2 In contrast, the 
Eastern Cape Province (former Transkei) of SA has one of the 
highest incidences of oesophageal squamous cell carcinoma 
(OSCC) in the world. This remains true despite recent 
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evidence to suggest that there may be a significant decrease in 
the incidence in the Eastern Cape Province.3,4 Squamous cell 
dysplasia is a precursor lesion in the development of OSCC.5 
Screening for OSCC in SA is not developed and not applied in 
clinical practice in private and public hospitals.6 
Surgery, in combination with chemotherapy or radiotherapy, 
offers the only chance of cure for OC. Resection rates of up to 
26.4% have been reported in the developed world.7 However, 
in South Africa, a recent report from Cape Town showed a 
much lower resection rate of 6.1%.8 The goal of surgery is 
an R0 resection containing ≥ 15 lymph nodes, which will 
allow adequate staging of lymph node status according 
to the National Comprehensive Cancer Network (NCCN) 
guidelines.9 There is lack of data from SA on the South African 
experience of oesophageal resection rates for malignancy and 
on the adequacy and quality of such resections. No data on 
morbidity and or mortality is available. 
This study was a retrospective review of histopathology 
reports from three different time periods ranging over 12 years 
and aimed to assess whether there was a change in the hospital 
incidence or histopathological subtypes of OC in KwaZulu-
Natal (KZN), SA. A further aim was to assess the resection 
rates and adequacy of resection for OC in KZN. 
Methods
A retrospective histopathology report review was carried 
out at Inkosi Albert Luthuli Central Hospital (IALCH), 
Durban, South Africa. The laboratory receives specimens 
from the Ethekwini region and from the North and South 
Coasts of KZN. The University of KZN Biomedical 
Research Ethics Committee (BREC) supplied class approval 
for creation of a comprehensive database on oesophageal 
cancer. The three comparative time periods selected were as 
follows: 2003–4 (TP1), 2008–9 (TP2) and 2013–14 (TP3). 
Oesophageal biopsies were accessed from the department 
of Anatomical Pathology database using SNOMED word 
search for “oesophagus” and “oesophageal” specimens. 
Histopathological reports based on either punch biopsy or 
oesophageal resections were analyzed. The sixth edition of the 
American Joint Committee on Cancer (AJCC)/International 
Union Against Cancer (UICC) tumor-node-metastasis 
(TNM) classification was used for TP1/TP2 and the seventh 
edition was used for TP3.10-12 The difference between the two 
classifications was that “squamous cell carcinoma in situ” was 
used in the 6th edition but the 7th edition classified carcinoma in 
situ as “high-grade squamous cell dysplasia”. In this paper we 
included “carcinoma in situ” in the category of “high-grade 
squamous cell dysplasia” to accommodate this difference and 
this was applied for the three TPs. Demographic data, the 
site of specimen biopsy and the type of specimen collection 
were also documented. Further information on resection 
specimens was documented including the type of tumour and 
grading, site of the tumour, resection margins and tumour 
staging according to the histopathologist’s final report. 
The site of tumour was based on the clinical history on the 
histopathology request form or reported level from the incisor 
teeth. The endoscopic classification of the level of OC was the 
measurement from the incisor teeth to the level of the lesion, 
with proximal being 15–18cm, middle 19–31cm and distal 
from 32 cm up to the level of oesophago-gastric junction.11  
Statistical analysis
Data was processed and analyzed using Stata 13.0 (StataCorp. 
2013. Stata Statistical Software: Release 13. College Station, 
TX: StataCorp LP.). Difference in continuous normally 
distributed variables by dichotomous group was analyzed 
using the Student’s T-test. Comparison of means across ≥ 3 
groups was analyzed using one way analysis of variance 
(ANOVA). Associations between categorical variables 
were assessed using the Pearson Chi-squared (χ2) test. If an 
expected cell count was less than 5 observations then the 
Fishers exact test was used instead. Relative changes (odds 
ratios) in cancer type by period were estimated using logistic 
regression. A p-value of < 0.05 was used to define statistical 
significance. 
Results 
A total of 1341 specimens were collected, and the breakdown 
per time period was as follows; TP1 521 (38.9%), TP2 346 
(25.8%) and TP3 474 (35.3%). There were 649 (48.3%) males 
and 642 females (47.8%) with a ratio of 1.01:1. Fifty subjects 
(3.7%) had no sex status specified. The mean age (among the 
1209 with specified age) was 60.8 years (SD ± 11.8). The 
ethnic distribution was as follows: 1197 (91.5%) Black, 66 
(5.1%) Asian, 25 (1.9%) White, 9 (0.7%) mixed ancestry and 
44 (3.2%) unknown.  The tumour type and differentiation are 
displayed in Table 1. The overall SCC to AC ratio was 15.9:1. 
There was an increase in the ratio in favor of SCC relative 
to AC from TP1 to TP3 (OR 1.29), though this was not 
statistically significant (p-value = 0.436). In TP2 there was a 
significant increase in AC relative SCC over this period (OR 
0.52; p-value = 0.024). 
A total of 74 (5.6%) patients underwent oesophageal 
resections over the study period and this is summarized in 
Table 2. There was a marginally significant decrease in the 
number of resections over the time periods from 33 (6%) in 
TP1 to 23 (7%) TP2 and 19 (4%) TP3 (p-value = 0.099). The 
tumour type resected was consistent with SCC predominating 
(84–87%). The number of resections of the upper and middle 
oesophagus decreased but this was not statistically significant 
(p-value = 0.275). The number of resections performed also 
decreased from 17 (51%) in TP1, 10 (43%) in TP2 and 6 (2%) 
in TP3 (p-value = 0.007).  A significantly lower rate of positive 
margins was observed from TP1 to TP3 (p-value = 0.001) 
along with an increase in the average number of lymph nodes 
resected; however this did not reach significance.
Discussion 
Squamous Cell Carcinoma (SCC) remained the most common 
histopathological cancer subtype (84.2%) without any change 
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Table 1: Tumour type and differentiation by time period
Type of tumour TP1: 2003-2004 TP2: 2008-2009 TP3: 2013-2014 Overall
Malignant 501 (9.6) 290 (83.8) 440 (92.8) 1231 (91.8)
SCC 449 (86.1) 254 (73.4) 395 (83.3) 1098 (81.2)
   G1 Well diff 3 (0.6) 0 (0) 0 (0) 3 (0.2)
   G2 Mod diff 360 (69) 230 (66.5) 304 (64.1) 894 (66.7)
   G3 Poor diff 30 (5.7) 8 (2.3) 9 (1.9) 47 (3.5)
   GX = G1 56 (10.7) 16 (4.6) 82 (17.3) 154 (11.5)
AC 25 (4.8) 27 (7.8) 17 (3.6) 69 (5.1)
Adenosquamous 3 (0.6) 0 (0) 1 (0.2) 4 (0.3)
NET 3 (0.6) 1 (0.3) 7 (1.5) 10 (0.7)
Kaposi Sarcoma 1 (0.2) 0 (0) 0 (0) 1 (0.1)
GIST 1 (0.2) 0 (0) 0 (0) 1 (0.1)
Other 19 (3.6) 8 (2.3) 20 (4.2) 16 (1.2)
Pre-malignant 20 (3.8) 56(16.2) 34 (7.2) 110 (8.2)
SC dysplasia 19 (3.6) 55 (15.9) 31 (6.5) 105 (7.8)
BO 0 (0) 1 (0.3) 3 (0.6) 4 (0.3)
Unknown 1 (0.2) 0 (0) 0 (0) 1 (0.1)
Total 521(38.9) 346 (25.8) 474 (35.3) 1341
SCC- Squamous cell carcinoma; AC - Adenocarcinoma; GIST - Gastrointestinal stromal tumour;  SC dysplasia - Oesophageal 
squamous cell dysplasia; BO - Barrett’s oesophagitis/Oesopheageal glandular dysplasia
Table 2: Characteristics of oesophageal resections by time period
Characteristic TP1 TP2 TP3 p-value
521 346 474
Number of  resections (%) 33 (6) 23 (7) 19 (4) 0,172
Position     
  Distal 18(54) 18 (78) 14 (74) 0,168
  Middle 14(42) 5(28) 5 (26)
  Upper 1 (3) 0 (0) 0 (0)
Type of tumour: n (%)     
AC 4 (12) 2 (9) 2 (11) 0,38
SCC 29 (87) 20 (87) 16 (84)
SCC is 0 (0) 1 (4) 1 (5)
T Staging     
  T4 17 (51) 10(43) 6 (32) 0,006
  T3 7 (21) 8 (35) 7 (37)
  T2 0 (0) 3 (13) 5 (26)
T1 0 (0) 0 (0) 0 (0)
Tis 0 (0) 1 (4) 0 (0)
  Tx 9 (27) 1 (4) 1 (5)
Resection     
Positive margins: n (%) 59 (15) 2 (9) 1 (5) <0.001
Lymph nodes per resection specimen: mean (SD) 4.8 (5.4) 5.4 (5.4) 5.7 (7.7) 0,862
SCC- Squamous cell carcinoma; AC - Adenocarcinoma     
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in the overall SCC to AC ratio. Similar results have been 
reported in Cape Town, SA, which is in keeping with trends in 
other developing countries. 
Gould et al. from Johannesburg in the Gauteng Province 
reported a decrease in the number of OC cases diagnosed, 
however this trend has not been shown in our study.3 
The results showed that the ratio of SCC to AC has remained 
constant. There was a decrease in the number of OC cases and 
an increase of AC diagnosed in TP2, but this did not reach 
statistical significance over the three time periods. A plausible 
explanation may be the endoscopic equipment failures that 
periodically disrupt endoscopic services at both regional and 
tertiary hospitals, resulting in false and apparent decreases in 
incidence.13 
Premalignant conditions (dysplasia and carcinoma in 
situ) for SCC represented 7.8% and Barret’s Oesophagitis 
(BO) represented 0.3% of cases. High-grade squamous cell 
dysplasia has been shown to be a significant risk factor in 
the development of SCC.5 The incidence of BO is not known 
amongst Black Africans in SA. 
The oesophageal resection rate of 5.6% was in keeping with 
the findings published from Cape Town.8 Resections were 
performed for lower T stages in TP2 and TP3. Unfortunately, 
the number of resection specimens with positive margins was 
higher than expected.  There was an unexpected low yield 
in the number of lymph nodes harvested considering the 
NCCN guidelines.9 The reason for this is unclear and whether 
it reflects inadequate surgical technique, histopathological 
under-sampling or underreporting remains to be elucidated. 
Survival outcomes data were unavailable.
OSCC remains the most prevalent cancer in SA and other 
developing countries as opposed to the developed world 
where AC is increasing in incidence.14 Our cohort has a low 
resection rate in keeping with a poorly resourced environment, 
which limits access to multi-modality treatment.
Low resection rates for OC unfortunately remain 
consistent. Any attempts to improve this will depend upon 
the development of dedicated multi-disciplinary teams in 
centralized centers. Standardization of surgical technique 
and histopathological reporting should be implemented to 
improve both the quality of resections and surgical outcomes. 
The study limitations include that it is retrospective and that 
actual operative patient outcomes are not known.
Conclusions
The study showed that SCC is still the most prevalent OC 
in our setting without any change in the subtype. Surgical 
margins and lymphadenectomy, although they showed 
improvement over the three TPs, were sub-optimal. The 
resection rates for OC are lower than those abroad, yet 
comparable to other SA centers. 
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